| 臺大學術典藏 |
2021-07-03T03:34:27Z |
Dovitinib induces apoptosis and overcomes sorafenib resistance in hepatocellular carcinoma through SHP-1-mediated inhibition of STAT3
|
Tai W.-T.; Cheng A.-L.; Shiau C.-W.; Liu C.-Y.; Ko C.-H.; Lin M.-W.; PEI-JER CHEN; Chen K.-F. |
| 臺大學術典藏 |
2021-07-03T03:34:27Z |
Androgen pathway stimulates MicroRNA-216a transcription to suppress the tumor suppressor in lung cancer-1 gene in early hepatocarcinogenesis
|
PEI-JER CHEN; Yeh S.-H.; Liu W.-H.; Lin C.-C.; Huang H.-C.; Chen C.-L.; Chen D.-S.; PEI-JER CHEN |
| 臺大學術典藏 |
2021-07-03T03:34:27Z |
Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy
|
Liu C.-H.; Liang C.-C.; Liu C.-J.; Tseng T.-C.; Lin C.-L.; Yang S.-S.; Su T.-H.; Hsu S.-J.; Lin J.-W.; Chen J.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:34:27Z |
High-resolution melting and real-time PCR for quantification and detection of drug-resistant HBV mutants in a single amplicon
|
Hsiao C.-C.; Chang J.; Wu J.-Y.; Liu W.-H.; Han S.-Y.; PEI-JER CHEN; Yeh S.-H. |
| 臺大學術典藏 |
2021-07-03T03:34:26Z |
PD-1 blockage reverses immune dysfunction and hepatitis B viral persistence in a mouse animal model
|
Tzeng H.-T.; Tsai H.-F.; Liao H.-J.; Lin Y.-J.; Chen L.; PEI-JER CHEN; Hsu P.-N. |
| 臺大學術典藏 |
2021-07-03T03:34:26Z |
Dovitinib sensitizes hepatocellular carcinoma cells to TRAIL and tigatuzumab, a novel anti-DR5 antibody, through SHP-1-dependent inhibition of STAT3
|
Chen K.-F.; Chen H.-L.; Liu C.-Y.; Tai W.-T.; Ichikawa K.; PEI-JER CHEN; Cheng A.-L. |
| 臺大學術典藏 |
2021-07-03T03:34:26Z |
Differential clinical and virologic impact of hepatitis B virus genotypes B and C on HIV-coinfected patients receiving lamivudine-containing highly active antiretroviral therapy
|
Sheng W.-H.; Hung C.-C.; Chang S.-Y.; Liu C.-J.; Chen M.-Y.; Hsieh S.-M.; Kao J.-H.; PEI-JER CHEN; Chang S.-C. |
| 臺大學術典藏 |
2021-07-03T03:34:25Z |
Young chronic hepatitis b patients with nucleos(t)ide analogue-induced hepatitis b e antigen seroconversion have a higher risk of HBV reactivation
|
Tseng T.-C.; Liu C.-J.; Su T.-H.; Yang H.-C.; Wang C.-C.; Chen C.-L.; Kuo S.F.-T.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:34:25Z |
Re-evaluation of the Carcinogenic Significance of Hepatitis B Virus Integration in Hepatocarcinogenesis
|
Jiang S.; Yang Z.; Li W.; Li X.; Wang Y.; Zhang J.; Xu C.; PEI-JER CHEN; Hou J.; McCrae M.A.; Chen X.; Zhuang H.; Lu F. |
| 臺大學術典藏 |
2021-07-03T03:34:25Z |
Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia
|
Afdhal N.H.; Giannini E.G.; Tayyab G.; Mohsin A.; Lee J.-W.; Andriulli A.; Jeffers L.; McHutchison J.; PEI-JER CHEN; Han K.-H.; Campbell F.; Hyde D.; Brainsky A.; Theodore D. |
| 臺大學術典藏 |
2021-07-03T03:34:25Z |
Inhibition of Bcl-2 improves effect of LCL161, a SMAC mimetic, in hepatocellular carcinoma cells
|
Chen K.-F.; Lin J.-P.; Shiau C.-W.; Tai W.-T.; Liu C.-Y.; Yu H.-C.; PEI-JER CHEN; Cheng A.-L. |
| 臺大學術典藏 |
2021-07-03T03:34:24Z |
IL-21R gene polymorphisms and serum IL-21 levels predict virological response to interferon-based therapy in Asian chronic hepatitis C patients
|
Hsu C.-S.; Hsu S.-J.; Liu W.-L.; Chen C.-L.; Liu C.-J.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:34:24Z |
A systematic review and meta-analysis of adjuvant interferon therapy after curative treatment for patients with viral hepatitis-related hepatocellular carcinoma
|
Huang T.-S.; Shyu Y.-C.; Chen H.-Y.; Yuan S.-S.; Shih J.-N.; PEI-JER CHEN |
| 臺大學術典藏 |
2021-07-03T03:34:24Z |
Influences of tobacco and alcohol use on hepatocellular carcinoma survival
|
Shih W.-L.; Chang H.-C.; Liaw Y.-F.; Lin S.-M.; Lee S.-D.; PEI-JER CHEN; Liu C.-J.; Lin C.-L.; Yu M.-W. |
| 臺大學術典藏 |
2021-07-03T03:34:23Z |
Mcl-1-dependent activation of Beclin 1 mediates autophagic cell death induced by sorafenib and SC-59 in hepatocellular carcinoma cells
|
Tai W.-T.; Shiau C.-W.; Chen H.-L.; Liu C.-Y.; Lin C.-S.; Cheng A.-L.; PEI-JER CHEN; Chen K.-F. |
| 臺大學術典藏 |
2021-07-03T03:34:23Z |
Predicting clinical outcome in a patient with chronic hepatitis B virus infection
|
Yang H.-I.; PEI-JER CHEN |
| 臺大學術典藏 |
2021-07-03T03:34:23Z |
Reduced Toll-like receptor 3 expression in chronic hepatitis B patients and its restoration by interferon therapy
|
Huang Y.-W.; Lin S.-C.; Wei S.-C.; Hu J.-T.; Chang H.-Y.; Huang S.-H.; Chen D.-S.; PEI-JER CHEN; Hsu P.-N.; Yang S.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:34:23Z |
Report from a Viral Hepatitis Policy Forum on implementing the WHO framework for global action on viral hepatitis in North Asia
|
Chen D.-S.; Locarnini S.; Wait S.; Bae S.-H.; PEI-JER CHEN; Fung J.Y.Y.; Kim H.S.; Lu S.-N.; Sung J.; Tanaka J.; Wakita T.; Ward J.; Wallace J. |
| 臺大學術典藏 |
2021-07-03T03:34:22Z |
Diagnostic performance of alpha-fetoprotein, lens culinaris agglutinin-reactive alpha-fetoprotein, des-gamma carboxyprothrombin, and glypican-3 for the detection of hepatocellular carcinoma: a systematic review and meta-analysis protocol.
|
Huang T.S.; Shyu Y.C.; Turner R.; Chen H.Y.; PEI-JER CHEN |
| 臺大學術典藏 |
2021-07-03T03:34:22Z |
Sorafenib and its derivative SC-49 sensitize hepatocellular carcinoma cells to CS-1008, a humanized anti-TNFRSF10B (DR5) antibody
|
Chen K.-F.; Chen H.-L.; Shiau C.-W.; Liu C.-Y.; Chu P.-Y.; Tai W.-T.; Ichikawa K.; PEI-JER CHEN; Cheng A.-L. |
| 臺大學術典藏 |
2021-07-03T03:34:22Z |
A real-time convective PCR machine in a capillary tube instrumented with a CCD-based fluorometer
|
Hsieh Y.-F.; Lee D.-S.; Chen P.-H.; Liao S.-K.; Yeh S.-H.; PEI-JER CHEN; Yang A.-S. |
| 臺大學術典藏 |
2021-07-03T03:34:22Z |
Hepatitis B virus reactivation in patients receiving cancer chemotherapy: Natural history, pathogenesis, and management
|
Liu C.-J.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:34:21Z |
Immunocompetent nontransgenic mouse models for studying hepatitis B virus immune responses
|
Tzeng H.-T.; Hsu P.-N.; PEI-JER CHEN |
| 臺大學術典藏 |
2021-07-03T03:34:21Z |
Quantitative hepatitis B core antibody level may help predict treatment response in chronic hepatitis B patients
|
Yuan Q.; Song L.-W.; Liu C.-J.; Li Z.; Liu P.-G.; Huang C.-H.; Yan Y.; Ge S.-X.; Wang Y.-B.; Peng C.-Y.; Zhang J.; Kao J.-H.; Chen D.-S.; PEI-JER CHEN; Xia N.-S. |
| 臺大學術典藏 |
2021-07-03T03:34:21Z |
Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion
|
Yang H.-C.; Chen C.-L.; Shen Y.-C.; Peng C.-Y.; Liu C.-J.; Tseng T.-C.; Su T.-H.; Chuang W.-L.; Yu M.-L.; Dai C.-Y.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:34:20Z |
Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up
|
Yu M.-L.; Lee C.-M.; Chen C.-L.; Chuang W.-L.; Lu S.-N.; Liu C.-H.; Wu S.-S.; Liao L.-Y.; Kuo H.-T.; Chao Y.-C.; Tung S.-Y.; Yang S.-S.; Kao J.-H.; Su W.-W.; Lin C.-L.; Yang H.-C.; PEI-JER CHEN; Chen D.-S.; Liu C.-J. |
| 臺大學術典藏 |
2021-07-03T03:34:20Z |
Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads
|
Tseng T.-C.; Liu C.-J.; Yang H.-C.; Su T.-H.; Wang C.-C.; Chen C.-L.; Hsu C.-A.; Fang-Tzu Kuo S.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:34:20Z |
Treatment for hepatocellular carcinoma with portal vein tumor thrombosis: The emerging role for radioembolization using yttrium-90
|
Lau W.-Y.; Sangro B.; PEI-JER CHEN; Cheng S.-Q.; Chow P.; Lee R.-C.; Leung T.; Han K.-H.; Poon R.T.P. |
| 臺大學術典藏 |
2021-07-03T03:34:19Z |
Antigenic analysis of divergent genotypes human Enterovirus 71 viruses by a panel of neutralizing monoclonal antibodies: Current genotyping of EV71 does not reflect their antigenicity
|
Chen Y.; Li C.; He D.; Cheng T.; Ge S.; Shih J.W.K.; Zhao Q.; PEI-JER CHEN; Zhang J.; Xia N. |
| 臺大學術典藏 |
2021-07-03T03:34:19Z |
Consensus recommendations and review by an International Expert Panel on Interventions in Hepatocellular Carcinoma (EPOIHCC)
|
Park J.-W.; Amarapurkar D.; Chao Y.; PEI-JER CHEN; Geschwind J.-F.H.; Goh K.L.; Han K.-H.; Kudo M.; Lee H.C.; Lee R.-C.; Lesmana L.A.; Lim H.Y.; Paik S.W.; Poon R.T.; Tan C.-K.; Tanwandee T.; Teng G.; Cheng A.-L. |
| 臺大學術典藏 |
2021-07-03T03:34:19Z |
Mother-to-infant transmission of hepatitis B virus infection: Significance of maternal viral load and strategies for intervention
|
Wen W.-H.; Chang M.-H.; Zhao L.-L.; Ni Y.-H.; Hsu H.-Y.; Wu J.-F.; PEI-JER CHEN; Chen D.-S.; Chen H.-L. |
| 臺大學術典藏 |
2021-07-03T03:34:19Z |
Selenium for sepsis: What have we learned so far?
|
Huang T.-S.; Shyu Y.-C.; Yuan S.-S.; PEI-JER CHEN |
| 臺大學術典藏 |
2021-07-03T03:34:18Z |
Effect of Parenteral Selenium Supplementation in Critically Ill Patients: A Systematic Review and Meta-Analysis
|
Huang T.-S.; Shyu Y.-C.; Chen H.-Y.; Lin L.-M.; Lo C.-Y.; Yuan S.-S.; PEI-JER CHEN |
| 臺大學術典藏 |
2021-07-03T03:34:18Z |
Phase 2 trial of linifanib (ABT-869) in patients with unresectable or metastatic hepatocellular carcinoma
|
Toh H.C.; PEI-JER CHEN; Carr B.I.; Knox J.J.; Gill S.; Ansell P.; McKeegan E.M.; Dowell B.; Pedersen M.; Qin Q.; Qian J.; Scappaticci F.A.; Ricker J.L.; Carlson D.M.; Yong W.P. |
| 臺大學術典藏 |
2021-07-03T03:34:18Z |
One step closer to an experimental infection system for Hepatitis B Virus? --- the identification of sodium taurocholate cotransporting peptide as a viral receptor
|
PEI-JER CHEN; Wu T.-C. |
| 臺大學術典藏 |
2021-07-03T03:34:17Z |
Application of Massively Parallel Sequencing to Genetic Diagnosis in Multiplex Families with Idiopathic Sensorineural Hearing Impairment
|
Wu C.-C.; Lin Y.-H.; Lu Y.-C.; PEI-JER CHEN; Yang W.-S.; Hsu C.-J.; Chen P.-L. |
| 臺大學術典藏 |
2021-07-03T03:34:17Z |
Antiviral therapy and hepatitis B virus-related hepatocellular carcinoma recurrence [2]
|
Yeh Y.-C.; PEI-JER CHEN; Lai M.-S. |
| 臺大學術典藏 |
2021-07-03T03:34:17Z |
Longitudinal Change of HBsAg in HBeAg-negative Patients with Genotype B or C Infection
|
Su T.-H.; Liu C.-J.; Tseng T.-C.; Liu C.-H.; Yang H.-C.; Chen C.-L.; PEI-JER CHEN; Kao J.-H.; Chen D.-S. |
| 臺大學術典藏 |
2021-07-03T03:34:16Z |
Liver sinusoidal endothelial cell lectin inhibits CTL-dependent virus clearance in mouse models of viral hepatitis
|
Liu B.; Wang M.; Wang X.; Zhao D.; Liu D.; Liu J.; PEI-JER CHEN; Yang D.; He F.; Tang L. |
| 臺大學術典藏 |
2021-07-03T03:34:16Z |
Long-term follow-up of children with postnatal immunoprophylaxis failure who were infected with hepatitis B virus surface antigen gene mutant
|
Hsu H.-Y.; Chang M.-H.; Ni Y.-H.; Jeng Y.-M.; Chiang C.-L.; Chen H.-L.; Wu J.-F.; PEI-JER CHEN |
| 臺大學術典藏 |
2021-07-03T03:34:16Z |
Telomerase-specific oncolytic adenoviral therapy for orthotopic hepatocellular carcinoma in HBx transgenic mice
|
Lin W.-H.; Yeh S.-H.; Yang W.-J.; Yeh K.-H.; Fujiwara T.; Nii A.; Chang S.S.-C.; PEI-JER CHEN |
| 臺大學術典藏 |
2021-07-03T03:34:16Z |
Association of IL28B genotypes with metabolic profiles and viral clearance rate in chronic hepatitis C patients
|
Hsu C.-S.; Hsu S.-J.; Chen H.-C.; Liu C.-H.; Jeng J.; Liu C.-J.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:34:15Z |
Seroprevalence of Hepatitis E Virus Infection among Swine Farmers and the General Population in Rural Taiwan
|
Lee J.-T.; Shao P.-L.; Chang L.-Y.; Xia N.-S.; PEI-JER CHEN; Lu C.-Y.; Huang L.-M. |
| 臺大學術典藏 |
2021-07-03T03:34:15Z |
Polymerase chain reaction with phase change as intrinsic thermal control
|
Hsieh Y.-F.; Yonezawa E.; Kuo L.-S.; Yeh S.-H.; PEI-JER CHEN; Chen P.-H. |
| 臺大學術典藏 |
2021-07-03T03:34:15Z |
Risk stratification of hepatocellular carcinoma in hepatitis B virus e antigen-negative carriers by combining viral biomarkers
|
Tseng T.-C.; Liu C.-J.; Chen C.-L.; Yang H.-C.; Su T.-H.; Wang C.-C.; Yang W.-T.; Kuo S.F.-T.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:34:15Z |
Serum microRNA-122 level correlates with virologic responses to pegylated interferon therapy in chronic hepatitis C
|
Su T.-H.; Liu C.-H.; Liu C.-J.; Chen C.-L.; Ting T.-T.; Tseng T.-C.; PEI-JER CHEN; Kao J.-H.; Chen D.-S. |
| 臺大學術典藏 |
2021-07-03T03:34:14Z |
ADAR2-mediated editing of miR-214 and miR-122 precursor and antisense RNA transcripts in liver cancers
|
Liu W.-H.; Chen C.-H.; Yeh K.-H.; Li C.-L.; Wu Y.-J.; Chen D.-S.; PEI-JER CHEN; Yeh S.-H. |
| 臺大學術典藏 |
2021-07-03T03:34:14Z |
Re-evaluating transarterial chemoembolization for the treatment of Hepatocellular Carcinoma: Consensus recommendations and review by an International Expert Panel
|
Cheng A.L.; Amarapurkar D.; Chao Y.; PEI-JER CHEN; Geschwind J.-F.; Goh K.L.; Han K.-H.; Kudo M.; Lee H.C.; Lee R.-C.; Lesmana L.A.; Lim H.Y.; Paik S.W.; Poon R.T.; Tan C.-K.; Tanwandee T.; Teng G.; Park J.-W. |
| 臺大學術典藏 |
2021-07-03T03:34:14Z |
Reduction of HBV replication prolongs the early immunological response to IFNα therapy
|
Tan A.T.; Hoang L.T.; Chin D.; Rasmussen E.; Lopatin U.; Hart S.; Bitter H.; Chu T.; Gruenbaum L.; Ravindran P.; Zhong H.; Gane E.; Lim S.G.; Chow W.C.; PEI-JER CHEN; Petric R.; Bertoletti A.; Hibberd M.L. |
| 臺大學術典藏 |
2021-07-03T03:34:14Z |
Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: A randomized trial
|
Liu C.-H.; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Liang C.-C.; Huang J.-F.; Hung P.-H.; Tsai H.-B.; Tsai M.-K.; Chen S.-I.; Lin J.-W.; Yang S.-S.; Su T.-H.; Yang H.-C.; PEI-JER CHEN; Chen D.-S.; Chuang W.-L.; Yu M.-L.; Kao J.-H. |
